These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 30850596)

  • 61. Smart thermo/pH responsive magnetic nanogels for the simultaneous delivery of doxorubicin and methotrexate.
    Salehi R; Rasouli S; Hamishehkar H
    Int J Pharm; 2015 Jun; 487(1-2):274-84. PubMed ID: 25895723
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Heparin modified graphene oxide for pH-sensitive sustained release of doxorubicin hydrochloride.
    Zhang B; Yang X; Wang Y; Zhai G
    Mater Sci Eng C Mater Biol Appl; 2017 Jun; 75():198-206. PubMed ID: 28415455
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Selenium-functionalized liposomes for systemic delivery of doxorubicin with enhanced pharmacokinetics and anticancer effect.
    Xie Q; Deng W; Yuan X; Wang H; Ma Z; Wu B; Zhang X
    Eur J Pharm Biopharm; 2018 Jan; 122():87-95. PubMed ID: 29032193
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Smart and dual-targeted BSA nanomedicine with controllable release by high autolysosome levels.
    Zhang Z; Dong C; Yu G; Cheng W; Liang Y; Pan Y; Li H; Ji H
    Colloids Surf B Biointerfaces; 2019 Oct; 182():110325. PubMed ID: 31301582
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Enhanced intracellular delivery and improved antitumor efficacy of doxorubicin by sterically stabilized liposomes modified with a synthetic RGD mimetic.
    Xiong XB; Huang Y; Lu WL; Zhang X; Zhang H; Nagai T; Zhang Q
    J Control Release; 2005 Oct; 107(2):262-75. PubMed ID: 16125816
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Effect of hydrophilic and hydrophobic polymers on permeation of S-amlodipine besylate through intercalated polymeric transdermal matrix: 3(2) designing, optimization and characterization.
    Rastogi V; Yadav P; Husain A; Verma A
    Drug Dev Ind Pharm; 2019 Apr; 45(4):669-682. PubMed ID: 30633579
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Dermal delivery of doxorubicin-loaded solid lipid nanoparticles for the treatment of skin cancer.
    Tupal A; Sabzichi M; Ramezani F; Kouhsoltani M; Hamishehkar H
    J Microencapsul; 2016 Jun; 33(4):372-80. PubMed ID: 27338131
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Recent Advances in Skin Penetration Enhancers for Transdermal Gene and Drug Delivery.
    Amjadi M; Mostaghaci B; Sitti M
    Curr Gene Ther; 2017; 17(2):139-146. PubMed ID: 28494734
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Enhanced drug delivery using sonoactivatable liposomes with membrane-embedded porphyrins.
    Wang X; Yan F; Liu X; Wang P; Shao S; Sun Y; Sheng Z; Liu Q; Lovell JF; Zheng H
    J Control Release; 2018 Sep; 286():358-368. PubMed ID: 30075210
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Targeted delivery of Doxorubicin by folic acid-decorated dual functional nanocarrier.
    Lu J; Zhao W; Huang Y; Liu H; Marquez R; Gibbs RB; Li J; Venkataramanan R; Xu L; Li S; Li S
    Mol Pharm; 2014 Nov; 11(11):4164-78. PubMed ID: 25265550
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Reversibly crosslinked hyaluronic acid nanoparticles for active targeting and intelligent delivery of doxorubicin to drug resistant CD44+ human breast tumor xenografts.
    Zhong Y; Zhang J; Cheng R; Deng C; Meng F; Xie F; Zhong Z
    J Control Release; 2015 May; 205():144-54. PubMed ID: 25596560
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Examination of fabrication conditions of acrylate-based hydrogel formulations for doxorubicin release and efficacy test for hepatocellular carcinoma cell.
    Bayramoglu G; Gozen D; Ersoy G; Ozalp VC; Akcali KC; Arica MY
    J Biomater Sci Polym Ed; 2014; 25(7):657-78. PubMed ID: 24580096
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Intracellular fluorescent thermometry and photothermal-triggered drug release developed from gold nanoclusters and doxorubicin dual-loaded liposomes.
    Gui R; Wan A; Liu X; Jin H
    Chem Commun (Camb); 2014 Feb; 50(13):1546-8. PubMed ID: 24382559
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Combinatorial effects of doxorubicin and retargeted tissue factor by intratumoral entrapment of doxorubicin and proapoptotic increase of tumor vascular infarction.
    Stucke-Ring J; Ronnacker J; Brand C; Höltke C; Schliemann C; Kessler T; Schmidt LH; Harrach S; Mantke V; Hintelmann H; Hartmann W; Wardelmann E; Lenz G; Wünsch B; Müller-Tidow C; Mesters RM; Schwöppe C; Berdel WE
    Oncotarget; 2016 Dec; 7(50):82458-82472. PubMed ID: 27738341
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Intracellularly Actuated Quantum Dot-Peptide-Doxorubicin Nanobioconjugates for Controlled Drug Delivery via the Endocytic Pathway.
    Sangtani A; Petryayeva E; Wu M; Susumu K; Oh E; Huston AL; Lasarte-Aragones G; Medintz IL; Algar WR; Delehanty JB
    Bioconjug Chem; 2018 Jan; 29(1):136-148. PubMed ID: 29191007
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Magnetically triggered nanovehicles for controlled drug release as a colorectal cancer therapy.
    Kuo CY; Liu TY; Chan TY; Tsai SC; Hardiansyah A; Huang LY; Yang MC; Lu RH; Jiang JK; Yang CY; Lin CH; Chiu WY
    Colloids Surf B Biointerfaces; 2016 Apr; 140():567-573. PubMed ID: 26705859
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Hyaluronic acid nanogels prepared via ortho ester linkages show pH-triggered behavior, enhanced penetration and antitumor efficacy in 3-D tumor spheroids.
    Yang G; Fu S; Yao W; Wang X; Zha Q; Tang R
    J Colloid Interface Sci; 2017 Oct; 504():25-38. PubMed ID: 28527297
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Sustained Delivery of Doxorubicin via Acetalated Dextran Scaffold Prevents Glioblastoma Recurrence after Surgical Resection.
    Graham-Gurysh E; Moore KM; Satterlee AB; Sheets KT; Lin FC; Bachelder EM; Miller CR; Hingtgen SD; Ainslie KM
    Mol Pharm; 2018 Mar; 15(3):1309-1318. PubMed ID: 29342360
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Smart pH/Redox Dual-Responsive Nanogels for On-Demand Intracellular Anticancer Drug Release.
    Yang H; Wang Q; Huang S; Xiao A; Li F; Gan L; Yang X
    ACS Appl Mater Interfaces; 2016 Mar; 8(12):7729-38. PubMed ID: 26960600
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Nanoparticles of esterified polymalic acid for controlled anticancer drug release.
    Lanz-Landázuri A; Portilla-Arias J; Martínez de Ilarduya A; García-Alvarez M; Holler E; Ljubimova J; Muñoz-Guerra S
    Macromol Biosci; 2014 Sep; 14(9):1325-36. PubMed ID: 24902676
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.